Two Sigma Securities LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 11,311 shares of the company’s stock, valued at approximately $1,022,000.
Other hedge funds have also recently modified their holdings of the company. Fifth Third Wealth Advisors LLC raised its position in shares of HealthEquity by 4.2% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after purchasing an additional 116 shares during the last quarter. Truist Financial Corp grew its position in HealthEquity by 4.9% during the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after purchasing an additional 119 shares during the last quarter. Fiduciary Trust Co increased its stake in HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC increased its stake in HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after purchasing an additional 123 shares in the last quarter. Finally, Merit Financial Group LLC increased its stake in HealthEquity by 8.9% during the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock valued at $200,000 after purchasing an additional 172 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.
Insider Activity
In other news, Director Adrian T. Dillon sold 7,632 shares of the company’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the sale, the director owned 62,395 shares in the company, valued at $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the company’s stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares in the company, valued at $4,963,180. The trade was a 4.31% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,456 shares of company stock worth $1,256,664 over the last ninety days. 1.60% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Report on HealthEquity
HealthEquity Stock Performance
Shares of NASDAQ HQY opened at $96.54 on Tuesday. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $107.62. The company has a 50 day simple moving average of $98.40 and a two-hundred day simple moving average of $88.06. The stock has a market cap of $7.98 billion, a price-to-earnings ratio of 34.85, a PEG ratio of 1.53 and a beta of 0.21.
HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings data on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The business had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. The firm’s revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current year.
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
